Here are four things to know about the company’s performance.
1. Philips posted €3.94 billion (an estimated $4.82 billion) in sales for the first quarter, down 2 percent from €4.03 billion (an estimated $4.93 billion) during the same period last year.
2. The company reported €1.53 billion (an estimated $1.87 billion) in sales for its diagnosis and treatment business segment, up 3 percent from €1.49 billion (an estimated $1.82 billion) during the first quarter of 2017.
3. Philips reported sales for its connected care and health informatics business segment remained constant at €663 million (an estimated $811.04 million) during the first quarter, compared to €732 million (an estimated $895.45 million) during the first quarter of 2017.
4. The company posted a net income from continuing operations of €94 million (an estimated $114.99 million), down 27 percent from €128 million (an estimated $156.58 million) one year prior.
More articles on health IT:
7 most interesting questions NIH Director Dr. Francis Collins answered during his Reddit AMA
In wake of WannaCry, NHS assessed 200 facilities on cybersecurity preparedness — None passed
‘The mind of a mathematician with the heart of a doctor’: athenahealth CTO Prakash Khot shares 4 thoughts on AI in healthcare
